Sodium Thiosulfate to Preserve Cardiac Function in STEMI
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 380 participants.
Also called NCT02899364
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 380 participants
- Registry
-
NCT02899364 -
2015-001006-34
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Unknown status
Technical summary
Registry record NCT02899364. Randomized; triple masking; primary purpose prevention. Start 2018-07-20 (actual); primary completion 2021-06-25 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sodium Thiosulfate to Preserve Cardiac Function in STEMI
- Acronym
- GIPS-IV
- Condition
- Myocardial Infarction
- Condition
- Heart Failure
- Intervention (Drug)
- Sodium thiosulfate
- Intervention (Drug)
- Sodium chloride 0.9%
- Intervention (Procedure)
- primary percutaneous coronary intervention
- Intervention (Other)
- cardiac magnetic resonance imaging
- Lead sponsor
- University Medical Center Groningen
Record details
- Record id
cardio:ct-nct02899364- Content hash
cd7a3eb49ddcdafbcd72fcd15f0fec87d4725b74f24b223ebc6b77fdc7689a71